logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

SUNAC SERVICES (01516) spends 371,300 Hong Kong dollars to repurchase 400,000 shares on April 27th.

date
17:41 27/04/2026
avatar
GMT Eight
Sunac Services (01516) announced that on April 27, 2026, it spent HKD 371,300 to repurchase 400,000 shares.
SUNAC SERVICES (01516) announced on April 27, 2026, that it will buy back 400,000 shares for a total of 371,300 Hong Kong dollars.
Related Articles
HK Stock
ZHONGYU ENERGY (03633) spent HKD 2.7405 million on April 27 to repurchase 1 million shares.
HK Stock
CITIC (00267): CITIC Offshore Helicopter (000099.SZ) reported a net profit attributable to shareholders of 93.1356 million yuan in the first quarter, an increase of 2.11% year-on-year.
HK Stock
Biocytogen Pharmaceuticals-B (02315) plans to invest 1.6 billion yuan to build an animal center and preclinical CRO service experimental facilities.
ZHONGYU ENERGY (03633) spent HKD 2.7405 million on April 27 to repurchase 1 million shares.
HK Stock
CITIC (00267): CITIC Offshore Helicopter (000099.SZ) reported a net profit attributable to shareholders of 93.1356 million yuan in the first quarter, an increase of 2.11% year-on-year.
HK Stock
Biocytogen Pharmaceuticals-B (02315) plans to invest 1.6 billion yuan to build an animal center and preclinical CRO service experimental facilities.
HK Stock
RECOMMEND
iQIYI’s AI Drama Faces Backlash Over Industry Dynamics
iQIYI’s AI Drama Faces Backlash Over Industry Dynamics
icon
26/04/2026
DeepSeek valuation jumps as Tencent and Alibaba reportedly in talks
DeepSeek valuation jumps as Tencent and Alibaba reportedly in talks
icon
26/04/2026
Intel first proposes intelligent PC concept as digital employee era sees “Lobster” and “Hermes” surge
Intel first proposes intelligent PC concept as digital employee era sees “Lobster” and “Hermes” surge
icon
26/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.